PALO ALTO, Calif., May 12 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive Healthcare 2006 Quarterly Analyst Briefing Presentation on the specialty pharmaceuticals market to be held on Wednesday, May 17, 2006 at 10:00am CDT / 11:00am EDT. Highlights of the briefing include: an analysis of specialty pharmaceuticals market, market sizing, merger and acquisition trends and business model adoption.
The specialty pharmaceuticals market is witnessing consolidation of top tier market participants through mergers and acquisitions, which is poised to alter the dynamics of the market. The increase in litigations and patent challenges creates additional risk of uncertainty and increased cost. However, with several multi-billion-dollar-a-year drugs poised to go off-patent, specialty pharmaceutical companies with strong generic focus are likely to benefit and accelerate growth.
This briefing will benefit specialty pharmaceutical companies, pharmaceutical and biotechnology companies looking for potential strategic partnerships by discussing emerging trends and providing forward projections for the North American Specialty Pharmaceutical Market.
“The specialty pharmaceutical market is witnessing considerable upswing in the generics segment and is likely to witness market consolidation through mergers and acquisitions, creating multi-billion dollar companies, which can directly compete with ‘Big-Pharma’ companies,” observes Frost & Sullivan Research Analyst Barath Shankar.
Frost & Sullivan will hold this conference call at 10:00 am (CDT) / 11:00 am (EDT) on Wednesday, May 17, 2006, which will provide industry participants an outlook of the specialty pharmaceuticals market. To participate, please email Melina Trevino at melina.trevino@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com .
Contact: Melina Trevino North America Corporate Communications, Healthcare P: 210.247.2403 F: 210.348.1003 E: melina.trevino@frost.comhttp://www.frost.com
Frost & Sullivan
CONTACT: Melina Trevino, North America Corporate Communications,Healthcare of Frost & Sullivan, +1-210-247-2403, or fax, +1-210-348-1003,or melina.trevino@frost.com
Web site: http://www.frost.com/
